Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort

ZnT8A should be included in routine evaluation at diabetes onset and is a valuable biological marker to classify newly-diagnosed diabetics. The predictive value in our high-risk subjects has to be confirmed.